Decitabine 67184-0535
Product NDC
67184-0535- Manufacturer
- Qilu Pharmaceutical Co., Ltd.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 12, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA212826
Need to source Decitabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Decitabine | 50 mg/20mL |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(1)
1 VIAL in 1 CARTON (67184-0535-1) / 20 mL in 1 VIAL